SARAH LYMPANY: Open Payments
NPI 1073185146 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,435 in 160 payments from 38 companies in 2025. Trend: 2023 $2,645 · 2024 $2,992 · 2025 $2,435
Food & beverage: $2,435
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 78 | $487 |
| Teva Pharmaceuticals USA, Inc. | 11 | $220 |
| UCB, Inc. | 7 | $210 |
| Alexion Pharmaceuticals, Inc. | 4 | $95 |
| Biogen, Inc. | 4 | $86 |
| PFIZER INC. | 4 | $80 |
| Eisai Inc. | 3 | $73 |
| ARGENX US, INC. | 3 | $66 |
| Amneal Pharmaceuticals LLC | 3 | $64 |
| JAZZ PHARMACEUTICALS INC. | 2 | $59 |
Products named: QULIPTA, AUSTEDO XR, UBRELVY, NURTEC ODT, ULTOMIRIS, Fintepla, Leqembi, VYVGART HYTRULO.
Industry payments across NC — which companies pay providers there.
